Similarly, upregulations of PEPCK and G6Pase were observed in both the SS and the NASH group, but the PEPCK and G6Pase expressions did not differ between SS and NASH groups. The gene discussed is G6PC1; the disease is metabolic dysfunction-associated steatohepatitis.